Ovince Saint Preux Accepts Sanction for Violation of UFC Anti-Doping Policy

Colorado Springs, Colo.– USADA announced today that Ovince Saint Preux, of Knoxville, Tenn., has accepted a three-month sanction for a violation of the UFC^® Anti-Doping Policy after testing positive for prohibited substances. 

Saint Preux, 36, tested positive for ostarine and di-hydroxy-LGD-4033, a metabolite of LGD-4033, as well GW1516 sulfone and GW1516 sulfoxide, which are metabolites of GW1516 (also known as GW-501516), as the result of an out-of-competition urine sample he provided on November 1, 2019. Ostarine and LGD-4033 are non-Specified Substances in the class of Anabolic Agents, while GW1516 is a non-Specified Substance in the category of Hormone and Metabolic Modulators. These substances are prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.

During an investigation into the circumstances of the positive test, Saint Preux provided sealed containers of products he was using for analysis at the World Anti-Doping Agency-accredited laboratory in Salt Lake City, Utah. Although no prohibited substances were listed on the supplement labels, the analysis revealed that the products contained ostarine, LGD-4033, and GW1516 for which Saint Preux tested positive.

Roberto Villa

Roberto Villa is the CEO, Founder, Executive Writer, Senior Editor of FightBook MMA. Has a passion for Combat Sports and also a podcast host for Sitting Ringside. He’s also a former MMA fighter and Kickboxer.